Literature DB >> 9789062

Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells.

J Ghosh1, C E Myers.   

Abstract

Diets high in fat are associated with an increased risk of prostate cancer, although the molecular mechanism is still unknown. We have previously reported that arachidonic acid, an omega-6 fatty acid common in the Western diet, stimulates proliferation of prostate cancer cells through production of the 5-lipoxygenase metabolite, 5-HETE (5-hydroxyeicosatetraenoic acid). We now show that 5-HETE is also a potent survival factor for human prostate cancer cells. These cells constitutively produce 5-HETE in serum-free medium with no added stimulus. Exogenous arachidonate markedly increases the production of 5-HETE. Inhibition of 5-lipoxygenase by MK886 completely blocks 5-HETE production and induces massive apoptosis in both hormone-responsive (LNCaP) and -nonresponsive (PC3) human prostate cancer cells. This cell death is very rapid: cells treated with MK886 showed mitochondrial permeability transition between 30 and 60 min, externalization of phosphatidylserine within 2 hr, and degradation of DNA to nucleosomal subunits beginning within 2-4 hr posttreatment. Cell death was effectively blocked by the thiol antioxidant, N-acetyl-L-cysteine, but not by androgen, a powerful survival factor for prostate cancer cells. Apoptosis was specific for 5-lipoxygenase-programmed cell death was not observed with inhibitors of 12-lipoxygenase, cyclooxygenase, or cytochrome P450 pathways of arachidonic acid metabolism. Exogenous 5-HETE protects these cells from apoptosis induced by 5-lipoxygenase inhibitors, confirming a critical role of 5-lipoxygenase activity in the survival of these cells. These findings provide a possible molecular mechanism by which dietary fat may influence the progression of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9789062      PMCID: PMC23752          DOI: 10.1073/pnas.95.22.13182

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

Review 1.  Arachidonic acid metabolism.

Authors:  P Needleman; J Turk; B A Jakschik; A R Morrison; J B Lefkowith
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

2.  Randomized double-blind, placebo-controlled clinical trial of a selective 5-lipoxygenase inhibitor (AA-861) for the prevention of seasonal allergic rhinitis.

Authors:  R J Ancill; Y Takahashi; Y Kibune; R Campbell; J R Smith
Journal:  J Int Med Res       Date:  1990 Mar-Apr       Impact factor: 1.671

3.  Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines.

Authors:  D P Rose; J M Connolly
Journal:  Prostate       Date:  1991       Impact factor: 4.104

4.  Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor.

Authors:  C Brideau; C Chan; S Charleson; D Denis; J F Evans; A W Ford-Hutchinson; R Fortin; J W Gillard; J Guay; D Guévremont
Journal:  Can J Physiol Pharmacol       Date:  1992-06       Impact factor: 2.273

5.  Bombesin stimulates the rapid activation of phospholipase A2-catalyzed phosphatidylcholine hydrolysis in Swiss 3T3 cells.

Authors:  S Currie; G L Smith; C A Crichton; C G Jackson; C Hallam; M J Wakelam
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

6.  cPLA2 is phosphorylated and activated by MAP kinase.

Authors:  L L Lin; M Wartmann; A Y Lin; J L Knopf; A Seth; R J Davis
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

7.  Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors.

Authors:  D W West; M L Slattery; L M Robison; T K French; A W Mahoney
Journal:  Cancer Causes Control       Date:  1991-03       Impact factor: 2.506

Review 8.  Probing the molecular program of apoptosis by cancer chemopreventive agents.

Authors:  L Fésüs; Z Szondy; I Uray
Journal:  J Cell Biochem Suppl       Date:  1995

Review 9.  Androgen regulation of programmed death of normal and malignant prostatic cells.

Authors:  J T Isaacs; P I Lundmo; R Berges; P Martikainen; N Kyprianou; H F English
Journal:  J Androl       Date:  1992 Nov-Dec

10.  Epidermal growth factor activates calcium channels by phospholipase A2/5-lipoxygenase-mediated leukotriene C4 production.

Authors:  M P Peppelenbosch; L G Tertoolen; J den Hertog; S W de Laat
Journal:  Cell       Date:  1992-04-17       Impact factor: 41.582

View more
  91 in total

1.  First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on Hemostasis.

Authors:  Reheman Adili; Benjamin E Tourdot; Katherine Mast; Jennifer Yeung; John C Freedman; Abigail Green; Diane K Luci; Ajit Jadhav; Anton Simeonov; David J Maloney; Theodore R Holman; Michael Holinstat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-08-03       Impact factor: 8.311

2.  Oxidative stress and antioxidant defenses in pregnant women.

Authors:  Claudio A M Leal; Maria R C Schetinger; Daniela B R Leal; Vera M Morsch; Aleksandro Schafer da Silva; João F P Rezer; André Valle de Bairros; Jeandre Augusto Dos Santos Jaques
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

Review 3.  Involvement of eicosanoids in the pathogenesis of pancreatic cancer: the roles of cyclooxygenase-2 and 5-lipoxygenase.

Authors:  Lawrence M Knab; Paul J Grippo; David J Bentrem
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

4.  Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase.

Authors:  Diane K Luci; J Brian Jameson; Adam Yasgar; Giovanni Diaz; Netra Joshi; Auric Kantz; Kate Markham; Steve Perry; Norine Kuhn; Jennifer Yeung; Edward H Kerns; Lena Schultz; Michael Holinstat; Jerry L Nadler; David A Taylor-Fishwick; Ajit Jadhav; Anton Simeonov; Theodore R Holman; David J Maloney
Journal:  J Med Chem       Date:  2014-01-06       Impact factor: 7.446

Review 5.  Polyunsaturated fatty acid metabolism in prostate cancer.

Authors:  Isabelle M Berquin; Iris J Edwards; Steven J Kridel; Yong Q Chen
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

6.  Inhibition of 5-lipoxygenase triggers apoptosis in prostate cancer cells via down-regulation of protein kinase C-epsilon.

Authors:  Sivalokanathan Sarveswaran; Vijayalakshmi Thamilselvan; Chaya Brodie; Jagadananda Ghosh
Journal:  Biochim Biophys Acta       Date:  2011-07-30

7.  Roles of Eicosanoids in Prostate Cancer.

Authors:  Kasem Nithipatikom; William B Campbell
Journal:  Future Lipidol       Date:  2008-08-01

8.  Expression of 5-lipoxygenase in human colorectal cancer.

Authors:  Labile Togba Soumaoro; Satoru Iida; Hiroyuki Uetake; Megumi Ishiguro; Yoko Takagi; Tetsuro Higuchi; Masamichi Yasuno; Masayuki Enomoto; Kenichi Sugihara
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

9.  Neutrophil gelatinase-associated lipocalin as a survival factor.

Authors:  Zhimin Tong; Xuli Wu; Dmitriy Ovcharenko; Jiuxiang Zhu; Ching-Shih Chen; James P Kehrer
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

10.  A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality.

Authors:  Jorge E Chavarro; Meir J Stampfer; Megan N Hall; Howard D Sesso; Jing Ma
Journal:  Am J Clin Nutr       Date:  2008-11       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.